Barristas Coffee Company (Pink: BCCI) has been such an incredible stock over the past couple months, just continuing to make investors buckets full of cash. BCCI went from a penny to $0.84 for a dynamite gain of 8,400%! As it has trickled all the way down around 72% off its recent high of $0.84, it could be time to get back in for a nice reversal trend opportunity.

BCCI has been brewing some interesting ventures over the past couple months including openings in New Jersey and Texas.

However, what is catching my eye on BCCI is that it looks to have made a nice support area and may start a nice reversal trend. Today, it traded 1.2 million shares and was up more than 25%.

The chart shows:

• BCCI broke through resistance at $.22 today and closed at the high of the day at $.23. If there is a break at the resistance level at $.271, the next resistance level isn’t until $.42!
• The RSI is pointing up directly into the buy zone at 52, which means a possible reversal trend could start here.
• The MACD is very near a golden cross and if there is an intersection that will be nice verification for a reversal.
• The ADX is showing reverting positive and negative lines, which are perfect in this situation.

The Bottom Line

BCCI is opening stores, unveiling billboards, and trying to setup its business model across North America. Since it is so far off its recent high and it is starting again to allure positive interest; BCCI has an excellent chance to start a nice reversal trend. Obviously, this is still a pink stock and you should trade accordingly. However, there is never incredible reward without risk.

Don’t forget to sign up for my free email alerts! You could have made a possible 23.8% on my SHMX alert today and 26.5% on JCOF on Monday!

Good Luck,

Ian Decker

Disclosure: No Positions

About InvestorSoup

InvestorSoup.com is committed to provide intelligent commentary and solid analysis of small cap stocks, micro-cap stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or “penny stock” market, which has traditionally been shunned by Wall Street. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Disclaimer

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Chart Play on Radian Group Inc. (RDN)

Personally, I hate PMI…and that is the business that Radian Group, Inc. (RDN) is in.  PMI is Private Mortgage Insurance and is the insurance that homeowners are forced to purchase when they are putting up less than 20% down when they purchase a house.  I have always been able to put a full 20% down on any  house I have bought (thankfully!) and have never had to deal with it.  I have, however, had many friends and family that have had to use it.  With the push for home ownership over the past decades, it seemed like a scam that Radian and other companies (like PMI and MTG) would push such high rate insurance on desperate homeowners.  Radian made tons of money over the past few years and enjoyed hefty profits and a high stock price….that is until the meltdown of 2008.

The worm has turned and now RDN is the one that needs some help.  I won’t go into great detail about the problems that RDN is facing, except to point you to their own earnings conference call from May 5th:  Click here to read.

All of this bad news is being reflected in the stock price.  RDN continues to make new 52-week lows.

The Chart on RDN

I see a short term “scalp” that seems to be setting itself up on Radian:

• Trend is down…but, the stock seems to like to rally periodically.  That is what I want my readers to look for!
• MACD is still bearish, but momentum is weak
• Stochastics are showing the stock is severely oversold
• RSI is saying the same
• OBV and Accum/Dist are showing the distribution in the stock is continuing

The Bottom Line

RDN does not appear to be in danger of bankruptcy…in the near term.  They actually have decent capital ratios, cash in the bank and while some 52% of their insurance portfolio is impaired in some way, the company actually is stating that they are confident that a large percentage of those loans will ultimately perform.  Seems like a huge stretch to me, but they seem to believe it.

The challenge in any stock that is dropping like RDN is picking the bottom.  Don’t know when that will be frankly, but the indicators are telling me that this stock could rise soon.  It may be only a short-term pop, but I could see the stock hit $6.00 again on any recovery.

Have fun,

Jeffrey Dean Brown

Disclosure:  No positions

About InvestorSoup

InvestorSoup.com is committed to provide intelligent commentary and solid analysis of small cap stocks, micro-cap stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or “penny stock” market, which has traditionally been shunned by Wall Street. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Disclaimer

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Theragenics Corp. (TGX)

Theragenics is a company that could be a good one for the watch list.  I like the company’s chart and it has a strong balance sheet and is profitable!

Theragenics Corporation (TGX) (from Yahoo! Finance) operates as a medical device company serving the cancer treatment and surgical markets primarily in the United States and Europe. It operates through two segments, Surgical Products and Brachytherapy Seed. The Surgical Products segment manufactures and distributes wound closure products…….and the Brachytherapy Seed segment involves in the production, marketing, and sale of TheraSeed, a palladium-103 prostate cancer treatment device; I-Seed, an iodine-125 based prostate cancer treatment device; and other related products and services.

I looked at the company and I see a strong balance sheet (debt is high<$24MM>, but coverage ratios are strong).  The company is profitable….but the margins are not impressive.  The company is on a minor growth curve averaging around a 5% top line increase yoy.  Several publications have tapped TGX as an acquisition candidate and with the stock trading below book value, it might be a good bet.

The Chart

I loaded up TGX’s chart with a number of indicators to see if I can divine where the stock could be heading next.   The stock is trading sideways right now, but the indicators could mean the stock has some upside potential.  I was taught, early in my stock career, that “Trend Trumps Oscillators”.  But, what do you do with a stock that has no trend?

The MACD should be watched to see if we get a crossover and if the MACD line can get above the “0″line and hold.

My short term target on this one is $2.25 (watch to see if it stalls at the $2.25 high or pushes through) and medium target is over $3.00 (especially if the buyout rumors can be substantiated).  The “conservative” stop loss is $1.90 based on the chart, but setting it that tight could get you stopped out of it.   I don’t see a huge downside on the stock right now (barring any bad news).  A good radar stock…IMO.

May all your trades be great,

Jeffrey Dean

Disclosure: No Positions

About InvestorSoup

InvestorSoup.com is committed to provide intelligent commentary and solid analysis of small cap stocks, micro-cap stocks, hot penny stocks and helping investors make informed decisions. Our focus is primarily on the underserved OTC stocks market, or “penny stock” market, which has traditionally been shunned by Wall Street. There are many hot penny stock opportunities present in the OTC market everyday and we seek to exploit these hot stock gains for our members before the average daytrader is aware of them.

Disclaimer

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

CSTR, CSUN, GS, ATHN, APKT, DNDN, SWKS, AEP, SHOO, PWER

Coinstar Inc. (NASDAQ: CSTR) is up 21.17% to $46.30 after posting Q1 earnings that were 8 cents a share higher than Wall Street expected. (NASDAQ:CSTR), ($CSTR)

China Sunergy Co. Ltd. (ADR) (NASDAQ: CSUN) is up 2.65% to $4.65 following strong results for its Q1. (NASDAQ:CSUN), ($CSUN)

Goldman Sachs Group Inc. (NYSE: GS) is down 8.25% to $147.02. Bank of America/Merrill Lynch analysts have downgraded Goldman Sachs from Buy to Neutral, and lowered their price target to $160 from $220. (NYSE:GS), ($GS)

athenahealth Inc. (NASDAQ: ATHN) is down 15.95% to $29.71 following earnings that missed expectations. The company said results were negatively impacted by increased investments, and expenses related to its recent accounting review. (NASDAQ:ATHN), ($ATHN)

Acme Packet Inc. (NASDAQ: APKT) is up 28.05% to $26.98 after reporting quarterly earnings of 16 cents per share, which was 6 cents better than analysts’ estimates. The company also hiked its 2010 outlook. (NASDAQ:APKT), ($APKT)

Dendreon Corp. (NASDAQ: DNDN) is up 12.89% to $56.65 following Thursday’s announcement of FDA approval of Provenge for the treatment of men with advanced prostate cancer. (NASDAQ:DNDN), ($DNDN)

Skyworks Solutions Inc. (NASDAQ: SWKS) is up 7.64% to $17.48 following Q2 results that beat estimates, and a strong forecast for its Q3. (NASDAQ:SWKS), ($SWKS)

American Electric Power Company Inc. (NYSE: AEP) is up 2.75% to $34.77 following a ratings upgrade. Jefferies has upgraded the company to Buy from Hold. (NYSE:AEP), ($AEP)

Steven Madden Ltd. (NASDAQ: SHOO) is up 5.09% to $58.46 on above-average volume. (NASDAQ:SHOO), ($SHOO)

Power-One Inc. (NASDAQ: PWER) is up 39.50% to $8.04 after posting strong results for its first-quarter. Net income came in at $3.8 million, or $0.04 per diluted share, compared to a net loss of $61 million, or $0.70 per share for the same period last year. (NASDAQ:PWER), ($PWER)

OOGI, MCET, CLRH, INCCE, CDXC, DNRR, AMEL, CCTR, ZVTK

I just can’t help myself!

There are so many penny stock plays that I could share with you that it is hard to limit it to these 9.   Some are the “usual suspects” i.e. ones that you see all the time (ZVTK, CCTR, AMEL) and others are new to me.

These are all penny and sub-penny stocks that are in play for reasons of news, volume or price.  Each one represents an opportunity to make money on the long or short side.  Let’s see which one works for you my readers.

Odyssey Oil & Energy Inc. (OTC: OOGI) is up 56.67% to $0.235 following the announcement of a strategic partnership with Hylem Water Ltd. The company will help Hylem raise $2.5 million in order to implement its business plan, and will take a 51% stake in the firm as a result of the transaction.  (OTC:OOGI), ($OOGI)

Great short candidate, although the stock has already fallen from its high of 30 cents intraday.  I have reviewed the PR’s and financials and there isn’t much there.  The company is still development stage in all aspects and doesn’t appear to be too close to revenues.

Still, the company does have some good prospects.  The challenge for a company like this is to stay focused enough to make at least one of their “businesses” succeed”

MultiCell Technologies Inc. (OTC: MCET) is up 38.89% to $0.0125 following the report that it was granted a European patent covering certain of its therapeutic candidates for the treatment of cancer. (OTC:MCET), ($MCET)

The granting of the European patent is big news for MCET and the market responded accordingly.  The question is with this one-day pop what will the follow up be.  The stock vaulted to $0.0178 intraday before falling back to $.014.

A big gap at open, but the potential gain was still almost 50% for the day.  I am not too impressed with MCET yet….it has several U.S. patents and it is yet to effectively commercialize them.  The Euro patents are great, but I would like to see MCET generate significant revenues before I got too excited.

Clear-Lite Holdings Inc. (OTC: CLRH) is up 46.94% to $0.360.  The company has said that it will be expanding into new lines of environmentally-friendly businesses that will provide additional revenue opportunities outside of its cutting-edge, eco-friendly lighting products.  (OTC:CLRH), ($CLRH)

International Consolidated Companies Inc. (OTC: INCCE) is up 46.15% to $0.0095 on above-average volume.  (OTC:INCCE)(OTC:INCCE)

ChromaDex Corp. (OTC: CDXC) is up 15.20% to $1.44.  The company has said that it received an investment from The Frost Group LLC, which would allow the company to pursue clinical studies and commercialization of its new pTeroPure™ pterostilbene.  (OTC:CDXC), ($CDXC)

This is one company that might be worth keeping track of.   It is already $1.44 and much of the recent good news appears burnt into the stock price.

However, their nutritional extract, pterostilbene, has enormous potential based upon what I have read and the fact that the Frost Group is “ponying up” an undisclosed amount of money.   It is being touted as the next generation “Resveratrol”.  Also, the fact that it is a nutraceutical means that approval will happen much faster than if it was a pharmaceutical.

Denarii Resources Inc. (OTC: DNRR) is up 16.67% to $0.0420.  The company has provided an update on its Chile Coal recovery project. (OTC:DNRR), ($DNRR)

Amerilithium Corp. (OTC: AMEL) is up 21.74% to $1.68 on above-average volume.  (OTC:AMEL). ($AMEL)

China Crescent Enterprises Inc. (OTC: CCTR) is down 3.24% to $0.0209.  The company has scheduled an on-demand management update Web cast for release tomorrow, April 27th.  (OTC:CCTR), ($CCTR)

Zevotek Inc. (OTC: ZVTK) is up 3.39% to $0.0061.  (OTC:ZVTK), ($ZVTK)

Don’t forget to sign up for my periodic trading alerts.  I have an awesome track record of penny stock and small cap picks that I hope you can benefit from.  Go to my signup page to sign up for my Investor Soup alerts.

Good luck and good trading,

Jeffrey Dean

Editor

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

CYBS, GILD, DEAR, BNVI, JNPR, PII, BA, AAPL, HBAN, EMC

CyberSource Corp. (NASDAQ: CYBS) is up 31.94% to $25.65. Visa (NYSE: V) has agreed to acquire CyberSource for a total consideration of approx.$2 billion to be paid with cash on hand. (NASDAQ:CYBS), ($CYBS)

Gilead Sciences Inc. (NASDAQ: GILD) is down 10.03% to $40.54 following a weaker-than-expected forecast for 2010. (NASDAQ:GILD), ($GILD)

Dearborn Bancorp Inc. (NASDAQ: DEAR) is up 92.67% to $2.89. The company posted its first quarterly profit in over a year as bad loan provisions declined. (NASDAQ:DEAR), ($DEAR)

Bionovo Inc. (NASDAQ: BNVI) is up 17.93% to $0.52 following the announcement made by the company yesterday that the U.S. PTO has issued a patent covering a method of using Bezielle for the treatment of metastatic breast cancer. (NASDAQ:BNVI), ($BNVI)

Juniper Networks Inc. (NYSE: JNPR) is down 5.93 to $29.69 % despite Q1 profit report. (NYSE:JNPR), ($JNPR)

Polaris Industries Inc. (NYSE: PII) is up 6.80% to $6.96. The company has reported quarterly profit that topped analysts’ estimates, bolstered by strong international sales. (NYSE:PII), ($PII)

The Boeing Company (NYSE: BA) is up 3.21% to $73.70 following a profit report that beat analysts’ expectations by six cents a share. (NYSE:BA), ($BA)

Apple Inc. (NASDAQ: AAPL) is up 5.60% to $258.26. The company has posted strong earnings that easily topped expectations. The company reported that sales of its iPhone jumped 131% to 8.75 million. (NASDAQ:AAPL), ($AAPL)

Huntington Bancshares Inc. (NASDAQ: HBAN) is up 13.90% to $6.64 after reporting profitability in its Q1. (NASDAQ:HBAN), ($HBAN)

EMC Corp. (NYSE: EMC) is up 1.49% to $19.70. The company has lifted its full-year profit and revenue outlook following record financial results in its Q1. (NYSE:EMC), ($EMC)

ARRY, IBM, NTRS, REED, KO, APH, PH, STT, SVU, ETN

The following are large and mid cap stocks that were in the news on Tuesday and might be in play for Wednesday.  My comments are indented with quotation marks.

Don’t forget to sign up for my Hot penny stock alerts?  Several times a week, I email information out to my members about micro cap stocks and penny stocks.   Once you are signed up, you will receive information on stocks trading from 1 cent to several dollars.  My focus is finding the best penny stocks that look like they are ready to move.  Sign up today!

Last week, my alert for LMCO was up over 63%.  Try and do that with AAPL!

That is just one example of how my members can benefit from my penny stock tips.

Array BioPharma Inc. (NASDAQ: ARRY) is up 32.28% to $4.00. The company has announced a $467 million cancer drug deal with Novartis. (NASDAQ:ARRY), ($ARRY)

This is huge for ARRY and is a “game changer” for the company.  However, all is not roses for ARRY.  They still are posting major losses every quarter, have high debt and are burning cash at a very high rate.  The deal is contingent on several performance benchmarks and traders got a little giddy with the stock today.

ARRY might have a day or two more run in it, but watch for it to crack because the shorters will be all over this one.

International Business Machines Corp. (NYSE: IBM) is down 2.30% to $129.19. The company has reported a 2% drop in new services contracts. (NYSE:IBM), ($IBM)

Northern Trust Corp. (NASDAQ: NTRS) is down 5.79% to $54.99 followng news of lower quarterly earnings. (NASDAQ:NTRS), ($NTRS)

Reed’s Inc. (NASDAQ: REED) is up 49.70% to $2.53. The company is seeing at least 20% increase in 2010 revenue following on record Q4 result. (NASDAQ:REED), ($REED)

The Coca-Cola Company (NYSE: KO) is down 1.72% to $54.37. The company has posted Q1 profit of $1.61 billion, 20% higher than the year-ago period. (NYSE:KO), ($KO)

Amphenol Corp. (NYSE: APH) is up 6.16% to $46.73 on stronger-than-expected Q1 results. (NYSE:APH), ($APH)

Parker-Hannifin Corp. (NYSE: PH) is up 0.39% to $69.66. The company has upped its outlook for fiscal year after reporting that Q3 profits nearly tripled. (NYSE:PH), ($PH)

State Street Corp. (NYSE: STT) is down 4.97% to $44.90 despite better earnings in Q1. (NYSE:STT), ($STT)

Supervalu Inc. (NYSE: SVU) is down 2.92% to $16.64. The company has warned that yearly profit could miss analysts’ forecasts. (NYSE:SVU), ($SVU)

Eaton Corp. (NYSE: ETN) is down 0.47% to $78.78. The company has announced a profit of $155 million in the Q1. (NYSE:ETN), ($ETN)

$ARRY, $IBM, $NTRS, $REED, $KO, $APH, $PH, $STT, $SVU, $ETN

Good luck and good trading

Jeffrey Dean

Editor

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

C, PALM, HAL, MTB, LLY, CRN, HAS, BAC, GS, BOH, SQNM

Have you signed up for my “Souper” hot penny stock alerts?  Several times a week, I email information out to my members about micro cap stocks and penny stocks.   Once you are signed up, you will receive information on stocks trading from 1 cent to several dollars.  My focus is finding the best penny stocks that look like they are ready to move.  Sign up today!

Just today, my alert for LMCO was up over 63%.  Try and do that with AAPL! That is just one example of how my members can benefit from my penny stock tips.

Citigroup Inc. (NYSE: C) is up 2.85% to $4.69. The company has posted a quarterly net income of $4.43 billion, or $0.15 per share, compared to $1.59 billion in the same quarter last year. (NYSE:C), ($C)

Palm Inc. (NASDAQ: PALM) is down 11.96% to $4.92 following a rating downgrade by Morgan Keegan. The stock was downgraded to Underperform from Market Perform. (NASDAQ:PALM) ($PALM)

Halliburton Company (NYSE: HAL) is down 0.79% to $31.39. The company has reported a 46% drop in Q1 profit as results in Latin America disappoint. (NYSE:HAL), ($HAL)

M&T Bank Corp. (NYSE: MTB) is down 1.22% to $83.22. M&T Bank has posted a 135% increase in net income to $150.9 million for the first quarter. (NYSE:MTB), ($MTB)

Eli Lilly & Co. (NYSE: LLY) $36.54 – The company has posted a 5% decline in Q1 profit, hurt by reform-related charges and research costs. (NYSE:LLY), ($LLY)

Cornell Companies Inc. (NYSE: CRN) is up 29.62% to $23.94 following the news that Geo Group has agreed to buy the company for about $374 million in cash and stock. (NYSE:CRN), ($CRN)

Hasbro Inc. (NYSE: HAS) is up 0.48% to $40.04. The company has reported that first-quarter profit rose nearly three-fold from a year ago, helped by strong toys sales. (NYSE:HAS), ($HAS)

Bank of America Corp. (NYSE: BAC) is down 1.82% to 18.07. The company has received an upgrade from JPMorgan Chase. (NYSE:BAC), ($BAC)

Goldman Sachs Group Inc. (NYSE: GS) is down 1.29% to $158.63. The company plans to release its first quarter 2010 financial results tomorrow at approximately 7:00 a.m. (ET). (NYSE:GS), ($GS)

Bank of Hawaii Corp. (NYSE: BOH) is up 3.95% to $50.52. The company has reported quarterly profit that beat forecasts. (NYSE:BOH), ($BOH)

Sequenom Inc. (NASDAQ:SQNM) is up 6.55% to $6.18 following the announcement made by the company today that it launched its next-generation mass spectrometry system. (NASDAQ:SQNM), ($SQNM)

Trade like you mean it,

Jeffrey Dean

Editor

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

MIPI, AAPL, MSFT, FAST, CPRX, TLB, BGNN, CCTR, FNXC, ZVTK

Whether driven by news, chart or promotions, stocks will move…like these stocks.  These stocks showed up on my radar screen and I think are worthy of attention.  They are a mix of large cap, small cap and penny stocks   My comments are highlighted by the quotation marks and I usually only comment on stocks under $5.

Keep in mind that blogs are only part of what I do.  I send out periodic alerts on micro cap and penny stocks.   When you sign up for alerts from my site, you will receive stocks from 1 cent to several dollars.  My focus is finding small cap and micro cap stocks that look like they are ready to move.  Sign up today! A few weeks back you missed SECI which gained 170%. Lots of opportunity for gains on Investor Soup.

Molecular Insight Pharmaceuticals Inc. (NASDAQ: MIPI) $3.62 +141.33% MIPI shares surge on trial results (NASDAQ:MIPI), ($MIPI)

Boy, I love FDA approvals.  So does MIPI. Looking at a year-chart tells you that MIPI might have farther to run.  It is definitely not a short candidate….yet.

Apple Inc. (NASDAQ: AAPL) $241.97 -0.13% Apple upgrades its line of Macbook Pro laptops (NASDAQ:AAPL), ($AAPL)

Microsoft Corp. (NASDAQ: MSFT) $30.31 -0.03% Samsung Electronics announces plans to include Microsoft PlayReady technology in a broad range of its consumer devices (NASDAQ:MSFT), ($MSFT)

Fastenal Company (NASDAQ: FAST) $54.11 +4.26% Fastenal’s Q1 profit tops expectations (NASDAQ:FAST), ($FAST)

Catalyst Pharmaceutical Partners Inc. (NASDAQ: CPRX) $2.36 +24.87% CPRX enters into definitive agreement with the National Institute on Drug Abuse to conduct U.S. Phase II clinical trial for cocaine addiction (NASDAQ:CPRX), ($CPRX)

CPRX got a trifecta of good news with its news of the agreement with the NDA: financial assistance, government stamp of approval and logistical assistance.  If this drug gets approved (somewhere down the road) it will be the ONLY FDA-approved drug for cocaine addiction.  That is huge!

The Talbots Inc. (NYSE: TLB) $14.99 +4.17% TLB shares rising after earnings top estimates (NYSE:TLB), ($TLB)

B Green Innovations Inc. (OTC: BGNN) $0.0030 +57.89% B Green Innovations announces its environmentally conscious anti-vibration pad will debut on QVC TV (OTC:BGNN), ($BGNN)

An infomercial stock…yippee! Even though it is QVC, this company is very far from being a hit on QVC.

Expect this one to come crashing down and soon.  Their product is all hype and their website looks like my 10-yr. old nephew did it.  It is a sub-penny so all bets are off on this one.  Be very careful with BGNN.

China Crescent Enterprises Inc. (OTC: CCTR) $0.0210 +35.48% China Crescent Enterprises announces it will hold a CFO Web cast to review its year-to-date financial performance on April 16 (OTC:CCTR), ($CCTR)

All I can add to this is the old maxim:  “buy on rumor, sell on news”.  The expectation is often greater than the reality.  I expect CCTR to drop on April 16th.  Call me cynical, but I have seen it too many times.

Fonix Corp. (OTC: FNXC) $0.0005 +25% (OTC:FNXC), ($FNXC)

This is a sub, sub-penny and highly volatile. The news is that they have signed a partnership with China Crescent Enterprises (see above).  That could be huge…or maybe a precursor to being bought out by CCTR?  Take a quick peek at FNXC’s balance sheet and you will run screaming.

Zevotek Inc. (OTC: ZVTK) $0.0055 +27.91% Zevotek announces it has hired a retail sales agency to take them to national retailers

I must admit that I love ZVTK.  I have spoken with company management and they strike me as “stand up guys”.  They are trying to build a company around a novel product – an air ionizer/light bulb that plugs in to your light socket.  They are a one product company, but I love the buzz and hype that surrounds this stock.

The retail sales agreement announcement could be the “turning of a corner” that ZVTK needs to rescue it from sub-penny land.  Stay tuned.  I, for one, am rooting for them.

————————————————————————————————————————————————-

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

HOTT, STRM, CML, RPC, DDSS, SMSC, PIR, MTCH, CBAI, NWMT

I am presenting a topical review of stocks that were in the news yesterday.  I am wondering if the DDSS news will be enough to move the stock.  I’m not sure why MTCH went down so much despite some great news.

Have a great day in the market!

Jeffrey Dean

Hot Topic Inc. (NASDAQ: HOTT) $7.84 +11.05% Hot Topic March comparable store sales decreased 7.5% (NASDAQ:HOTT), ($HOTT)

Streamline Health Solutions Inc. (NASDAQ: STRM) $2.56 +28.33% Streamline Health Solutions swings to quarterly and full-year profit (NASDAQ:STRM), ($STRM)

Compellent Technologies Inc. (NYSE: CML) $13.38 -23.80% Compellent Technologies cuts Q1 revenue guidance (NYSE:CML), ($CML)

Radient Pharmaceuticals Corp. (AMEX: RPC) $0.72 +89.47% Radient Pharmaceuticals shares rally after company announces its FDA-approved test may change how people screen for early cancer detection (AMEX:RPC), ($RPC)

Labopharm Inc. (NASDAQ: DDSS) $1.47 +2.80% Labopharm subsidiary completes licensing, distribution agreement with Nippon Shinyaku of Japan (NASDAQ:DDSS), ($DDSS)

Standard Microsystems Corp. (NASDAQ: SMSC) $26.12 +8.16% Standard Microsystems shares rise after earnings top estimates (NASDAQ:SMSC), ($SMSC)

Pier 1 Imports Inc. (NYSE: PIR) $8.15 +12.26% Pier 1 Imports shares up on profit report (NYSE:PIR), ($PIR)

Matech Corp. (OTC: MTCH) $0.0055 -20.25% Matech expects to see increased contracts for its revolutionary EFS technology as states pledge significant investments in infrastructure (OTC:MTCH), ($MTCH)

Cord Blood America Inc. (OTC: CBAI) $0.0101 -1.94% Cord Blood America names an advocate for saving cord blood stem cells as official spokesperson (OTC:CBAI), ($CBAI)

NewMarket Technology Inc. (OTC: NWMT) $0.0106 -11.67% New Market Technology expanding operations into Vietnam (OTC:NWMT), ($NWMT)

———————————————————————————————————————————————-

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Good Morning Trader!

With gold trading this week around $1,134 per oz. it’s obviously a great time to be a gold exploration and mining company—especially one that’s already pulling gold out of the ground like there’s no tomorrow!

That’s why I am excited to bring you your next trading opportunity: continue

MON, JCDA, BAC, AAPL, SPF, MSFT, EMAN, SNEY, BEDA, TADF

Monsanto Company (NYSE: MON) $69.01 -1.13% Monsanto reports earnings miss; warns won’t meet previously announced financial targets (NYSE:MON), ($MON)

Jacada Ltd. (NASDAQ: JCDA) $1.80 +21.63% Jacada enters into material agreement with a large U.S.-based provider of digital TV services (NASDAQ:JCDA), ($JCDA)

Bank of America Corp. (NYSE: BAC) +18.72 +1.23% Barclays analyst raises its 2010 EPS estimate for BAC (NYSE:BAC), ($BAC)

Apple Inc. (NASDAQ: AAPL) $241.10 +0.65% USPTO publishes 16 newly granted Apple patents-Report (NASDAQ:AAPL), ($AAPL)

Standard Pacific Corp. (NYSE: SPF) $5.09 +7.61% Standard Pacific shares rise on Cramer’s positive sentiment to the company (NYSE:SPF), ($SPF)

Microsoft Corp. (NASDAQ: MSFT) $29.46 +0.48% Microsoft unveils Microsoft Dynamics CRM for nonprofits and nongovernmental organizations (NASDAQ:MSFT), ($MSFT)

eMagin Corp. (OTC: EMAN) $4.38 +4.29% eMagin showcasing its advanced OLED microdisplays at the SPIE Defense, Security, and Sensing 2010 Symppsium (OTC:EMAN), ($EMAN)

Sunergy Inc. (OTC: SNEY) $0.0400 +14.29% Sunergy provides update on its petroleum supply efforts in Ghana (OTC:SNEY), ($SNEY)

Bederra Corp. (OTC: BEDA) $0.0018 +38.46% BEDA shares soar on strong volume surge (OTC:BEDA), ($BEDA)

Tactical Air Defense Services Inc. (OTC: TADF) $0.0038 +35.71% TADF shares up on higher volume (OTC:TADF), ($TADF)

________________________________________________________________________________________

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

KERX, AAPL, NADX, INTC, SMMX, MSFT, BGBR, OWVI, AMEL, CTCC

These are stocks that are “in play”…large cap, small cap and micro cap.  All are of interest, but I focus mainly on the micro cap (penny stocks), since that is what my site is about.  Usually stocks under $5 is what I focus on.

Keryx Biopharmaceuticals (NASDAQ: KERX) $3.31  +20.80%  Keryx, AEterna Zentaris cancer treatment receives faster FDA review  (NASDAQ:KERX), ($KERX)

Apple Inc. (NASDAQ: AAPL) $237.10  +0.48%  Apple sells 300,000 iPads on first day; users download 250,000 e-books (NASDAQ:AAPL), ($AAPL)

National Dentex Corp. (NASDAQ: NADX) $16.83  +67.98%  National Dentex enters into definitive agreement with GDC Holdings, shares jump (NASDAQ:NADX) ($NADX)

Intel Corp. (NASDAQ: INTC) $22.61  +0.98%  Citi analyst positive on the semiconductor sector (NASDAQ:INTC), (NASDAQ:INTC)

Symyx Technologies Inc. (NASDAQ: SMMX) $5.46  +22.15% Accelrys (NASDAQ: ACCL) and Symyx Technologies announce merger agreement (NASDAQ:SMMX), ($SMMX)

Microsoft Corp. (NASDAQ: MSFT) $29.34  +0.62% eWeek.com: Microsoft could see consumer comeback, says analyst (NASDAQ:MSFT), ($MSFT)

Big Bear Mining Corp. (OTC: BGBR) $0.900  +18.42%  Big Bear Mining announces options agreement with Rubicon Minerals for 100% Interest in Red Lake Gold Property (OTC:BGBR), ($BGBR)

Editor’s Note: BGBR has just begun trading (as you can see from the chart).  It has a lot going for it, but it is a bit overheated and is “getting ahead of itself imo.  Watch for a day or two more of possible gains and then a sharp correction.  Here is a link to Yahoo! finance: BGBR Info.

BGBR is so new that it isn’t even listed on StockCharts.com!

One World Ventures (OTC: OWVI) $0.0036  +9.09%  One World Ventures announces 1World Cash launching in Hong Kong (OTC:OWVI), ($OWVI)

Amerilithium Corp. (OTC: AMEL) $1.35  +3.85%  Americana project poised to take advantage of the North American lithium market, says Company (OTC:AMEL), ($AMEL)

Editors Note: I really like AMEL.  Their stock price might be a bit inflated for what they have in way of revenues (um…zero), but they have an incredible story and strong momentum in the way of global lithium mining properties they control and the market demand for lithium.  The company has really put together a great deal of info for investors.  Read their 1Q presentation by clicking here.

Clean Coal Technologies Inc. (OTC: CCTC) $0.157  +17.16%  Clean Coal Technologies multi-million-dollar deals in both China and India featured in Business Week magazine (OTC:CCTC), (OTC:CCTC)

Editor’s Note: CCTC has been much in the news lately with investors and traders (read: shorters) fighting over the stock.  The company even took the extraordinary step of addressing rumors in a press release.  It is still a development stage company with no revenues…lots of promise though.  Not for the weak trader.

———————————————————————————————————————————————-

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

RIMM, JBLU, JOSB, ISCO, HEAT, HON, ZZ, ATSG, MU, RAD

Research In Motion Ltd. (USA) (NASDAQ: RIMM) $73.97 -1.26% RIMM’s quarterly results fall short of analysts’ expectations (NASDAQ:RIMM), ($RIMM)

JetBlue Airways Corp. (NASDAQ: JBLU) $5.58 +1.45% (NASDAQ:JBLU), ($JBLU) JetBlue Airways form partnership with American Airlines to offer direct connections through New York and Boston

Jos. A. Bank Clothiers Inc. (NASDAQ: JOSB) $54.72 +5.80% Jos. A. Bank Clothiers Q4 earnings, sales top estimates (NASDAQ:JOSB), ($JOSB)

International Stem Cell Corp. (OTC: ISCO) $2.26 -11.02% ISCO subsidiary signs distribution agreement with Veritas Corp. to distribute its human cell culture products throughout Japan (OTC:ISCO), ($ISCO)

SmartHeat Inc. (NASDAQ: HEAT) $10.74 -14.22% SmartHeat earnings fall short of estimates (NASDAQ:HEAT), (NASDAQ:HEAT)

Honeywell International Inc. (NYSE: HON) $45.27 +0.71% Analysts boost price targets on HON after strong Q1 guidance (NYSE:HON), ($HON)

Sealy Corp. (NYSE: ZZ) $3.49 -4.38% Piper Jaffray reiterates “Overweight” on Sealy; ups price target to $5

Air Transport Services Group Inc. (NASDAQ: ATSG) $3.34 +44.81% Air Transport Services subsidiary ABX Air has entered into a new five-year agreement with DHL (NASDAQ:ATSG), ($ATSG)

Micron Technology Inc. (NASDAQ: MU) $10.37 -3.89% Micron Technology turns a profit in Q2, helped by higher DRAM sales (NASDAQ:MU), ($MU)

Rite Aid Corp. (NYSE: RAD) $1.50 -11.24% Rite Aid shares decline on Q4 results, weak outlook (NYSE: RAD), ($RAD)

I am jumping around a bit with these chart picks, but all are interesting to me.

Hemispherx Biopharma, Inc. (NYSE Amex:HEB) is a favorite play in the penny stock space.  Our chat room, Stockhideout.com once even had a chat room dedicated to HEB when the stock had its big run up last May.  HEB is a “great little trader” and should be watched to see if it continues this bullish trend.  In addition, you are welcome to read a research report on HEB that I wrote and posted to my site earlier this week:  click here for link

BioCentric Energy Holdings, Inc. (Pinksheets:BEHL) is a stock that I can’t quite get a handle on.  They are a alt energy play (algae photobioreactors).  They play the PR game very well, but much of what you read from PR’s is “glowingly” positive….substantive information is lacking.  As a former CPA, I would love to see them get on the 10-Q, 10-K bandwagon.  In addition, they also are woefully underfunded for what they claim they are going to do.

BioElectronics Corp. (Pink Sheets:BIEL) is pharma lite.  They have a product line of inexpensive,  disposable drug-free anti-inflammatory devices.  They have lots of PR’s about distribution, sales and other positive milestones achieved but, like BEHL, no substantive info available.  It is hard for me to take news from pinksheet companies ” on faith”.  I am wondering if BIEL can bounce off this level.

Cell Therapeutics, Inc. (NASDAQCM:CTIC) is a dead man walking.  I still don’t see how this compay is even still around.  Class action law suits, FDA problems, financial problems have all beset CTIC.  I love reading the posts from the boards about how CTIC is going to go down in flames.  From everything I see, I am thinking that this company will be a sub-penny in the very near future.  However, traders are so passionate about the company that any good news could cause a surge.  That is why stock investing is so much fun.

——————————————————————————————————————————————-

<!– /* Font Definitions */ @font-face {font-family:”Cambria Math”; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1107304683 0 0 159 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:”"; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:”Times New Roman”,”serif”; mso-fareast-font-family:”Times New Roman”;} p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing {mso-style-priority:1; mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:”"; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:”Times New Roman”,”serif”; mso-fareast-font-family:”Times New Roman”;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page Section1 {size:8.5in 11.0in; margin:1.0in 1.0in 1.0in 1.0in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.Section1 {page:Section1;} –>

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

I was looking for a title for an analysis of shipping stocks and what better words than “Anchors Aweigh”.  Of course, the minute I said it, I started to sing the Navy Anthem.  My Dad served in the Navy during WWII and I will always be a Navy man.  Right now, that song is running through my head.

I picked 4 companies that, to me, represent the best in the shipping industry: SHIP, OCNF, DRYS and SINO.

Seanergy Maritime Holdings Corporation (NASDAQ:SHIP) – A company that is flying under the radar.  It is profitable, 95% of its fleet has contract coverage (meaning they are leased out under contract for all of 2010), they recently raised capital, they are retiring debt, etc…  Definitely one to put on the radar!

DryShips Inc. (NASDAQ:DRYS) - the most well known of the shipping stocks – DRYS has been trading sideways since May of 2009 in a band between $5 and $8.  That is great if you are a short-term trader.

OceanFreight Inc. (NASDAQ:OCNF) – OCNF has been a disappointing trade for most of the year.  Like DRYS it is highly volatile…which is a good thing for traders.  Their financials are a mess, but the global economic recovery might keep them “afloat”.  Definitely the “weakest link in the chain”.

Sino-Global Shipping America, Ltd. (Nasdaq:SINO) – Don’t make the same mistake I did.  SINO is not a shipping company in the sense that these other three companies are.  They actually provide shipping agency services and are firmly entrenched in some of the busiest Chinese ports.   They are highly profitable and have a rock-solid Balance Sheet.  What originally got traders fired up about the stock was that they had more cash per share than share price (before the recent run up).  Might be a good stock to keep an eye on.

——————————————————————————————————————————————

<!– /* Font Definitions */ @font-face {font-family:”Cambria Math”; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1107304683 0 0 159 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:”"; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:”Times New Roman”,”serif”; mso-fareast-font-family:”Times New Roman”;} p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing {mso-style-priority:1; mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:”"; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:”Times New Roman”,”serif”; mso-fareast-font-family:”Times New Roman”;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page Section1 {size:8.5in 11.0in; margin:1.0in 1.0in 1.0in 1.0in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.Section1 {page:Section1;} –>

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

I get emails from members and readers all the time about stocks they want me to look at and stocks they personally like (or hate).  Two of my best emailers are Jeff D. and Anat P.  One thing they have in common is:

Labopharm, Inc. (DDSS)

It seems that they are both investors (albeit unwillingly) when they would rather be traders.  What that means is that both of them are sitting on losing positions on a stock that really ticks them off. Why, they wonder, did the dang stock go DOWN when it had good news and FDA approvals?

I wonder the same thing.

Back on the 9th of February, I blogged DDSS for Investor Soup.  While I tried to figure out what happened then, I don’t have any better idea now than I did then.  At $1.82, I thought that traders should watch it in case it was bottoming out.   Well, it kept falling and is now “basing” in the $1.40 range.

Actually, I do have an idea why DDSS is stuck and won’t budge from this level.  It’s called

APATHY!

Nobody cares (except Anat, Jeff, me and maybe you).  I looked on Seekingalpha.com and found no recent articles.  I rely upon SA for a lot of good ideas and research on pharma.  Nobody on that site cares.  The boards are just recycling old information and innuendo and even posters are getting bored.  Volume, as I already mentioned, is drying up.

There are no large short positions in the stock, the financials are pretty good for a pharma company, they just raised a great deal of cash…all good stuff.  But nothing is moving the stock.

Let’s look at the chart to see if we can get some insight there:

DDSS is putting out PR that they are expecting to announce a marketing deal soon and begin the rollout of their newest drug, Oleptro, in the 3rdQ of 2010.  What are we to do until then? jk

For those who are already in the stock and underwater (Jeff and Anat), I wish I had a working crystal ball.  My hunch is that this level is a durable base in the stock and it should bounce off of this level given news or an increase in buying pressure.  Anyone new to the stock should watch for any breaks off of this level.  A break down should be “cutting your losses time” and any upwards bounce should be bracketed tightly.  Absent any stellar news from the company, any bounces might be short-lived.

Good luck and let me know YOUR thoughts on DDSS.  I will post the best comments in a blog later in the week.  My email is editor@investorsoup.com.

Good luck and good trading,

Jeffrey Dean, Editor

————————————————————————————————————————————————

<!– /* Font Definitions */ @font-face {font-family:”Cambria Math”; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1107304683 0 0 159 0;} @font-face {font-family:Cambria; panose-1:2 4 5 3 5 4 6 3 2 4; mso-font-charset:0; mso-generic-font-family:roman; mso-font-pitch:variable; mso-font-signature:-1610611985 1073741899 0 0 159 0;} /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:”"; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:”Times New Roman”,”serif”; mso-fareast-font-family:”Times New Roman”;} p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing {mso-style-priority:1; mso-style-unhide:no; mso-style-qformat:yes; mso-style-parent:”"; margin:0in; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:”Times New Roman”,”serif”; mso-fareast-font-family:”Times New Roman”;} .MsoChpDefault {mso-style-type:export-only; mso-default-props:yes; font-size:10.0pt; mso-ansi-font-size:10.0pt; mso-bidi-font-size:10.0pt;} @page Section1 {size:8.5in 11.0in; margin:1.0in 1.0in 1.0in 1.0in; mso-header-margin:.5in; mso-footer-margin:.5in; mso-paper-source:0;} div.Section1 {page:Section1;} –>

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Neither InvestorSoup.com nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Cord Blood America was one of my best picks for 2009 (not my best, but close).  I had correctly called its September move (as the chart below will indicate).  I think that it might be time to take another look at Cord Blood America, Inc. (CBAI). Here is a link to my earlier blog.

Truthfully, it has been flogged unmercifully in the penny stock press.  It has been hailed as everything from the next Genentech to the next Spongetech.  I think the truth is somewhere in the middle.

CBAI is a stock built on hype.  It really hasn’t proven that its business model can actually work.  My wife and I have 4 kids and after each birth we were given the opportunity to harvest cord blood.  We declined each time…too expensive, the value to our children wasn’t clear in our mind, logistics of storing and accessing it….a whole host of reasons.

Having said all this, I think that CBAI might actually make it….at least long enough for traders to make some money. I have been reading the press releases and the company is taking great pains to both dazzle and teach.  Glitzy Las Vegas-style openings are contrasted with PR’s that tell of debt extinguishments, agreements signed, alliances gained, etc…  The truth is that CBAI lives a hand-to-mouth existence.  It has little or no cash and negative cash flow.  Debt is less of a problem than it was in ’09 with some debt being retired, but they are not “out of the woods”.

I think the chart is positive and if CBAI can catch fire, I would expect to see some strong gains.

Here is the chart

CBAI seems to be consolidating at this level (as my chart indicates).    Any break below the current price of $.009 and the stock should be avoided.  I don’t believe that it will weaken, but, then again, my crystal ball is in the shop.

Good luck and good trading,

Jeffrey Dean

Editor

First a personal update:  Friday’s blog was kind of “doom and gloom” when I was stuck in the middle of a power outage (second year in a row for NH).  Even thought I got power back relatively quickly, I am still shopping online for an emergency generator.  Family is fine, house is safe and my section of NH is no longer a third-world country.  It is amazing how we take important things (like power) for granted.

Now…on to stocks.

My scans today produced NightHawk Radiology Holdings, Inc. (NHWK). Nighthawk is at the end of a prolonged decline in its stock price IMO.  This might be a good time to put it on the radar.  If it recovers from its February swoon and embarks on a climb like last year, you will like me very, very much.

Here is what I am talking about (1 yr. chart for NHWK)

NHWK is actually a very impressive company.  They have a dominant market position in their industry.  They provide services to radiology groups and hospitals throughout the United States.  NHWK provides a complete suite of solutions to doctors and hospitals, including professional services, business services, and its advanced, proprietary clinical workflow technology.  The company claims to provide round-the-clock services for for approximately 1,560 sites or 27% of all hospitals in the United States.   That is pretty impressive!

What is also impressive is that they make money.  Revenues of $162 million in ’09, but a loss in 2009 due to a $68.7MM  goodwill impairment charge (so, I wouldn’t hold it against them).  L-T debt of $77MM, but great liquidity ratios.  Plenty of cash in the bank ($32.29MM) and over $1.37 in cash per share.

Here is the 3 month chart so traders can see in greater detail what is going on.

Here is my final analysis.  The table below is a chart of NHWK’s highs and lows during the last year.  Lots of volatility and nice bounces off lows to post highs again.  A trader could make a great profit of trading these swings.

Do you see why I say that this is a great radar stock?

I will be watching it myself.

Good luck and good trading,

Jeffrey Dean

Editor

I got an email yesterday  from one of my members (Jeff D.) asking me my opinion on what happened to Labopharm, Inc. (DDSS).  Jeff was at a loss to explain why DDSS’ shares dropped so preciptiously after getting FDA approval on one of their signature drugs.  In some ways, so am I.

Headlines like this one:

Labopharm Receives FDA Approval For OLEPTRO(TM)

usually means that a drug stock will rocket upwards.  Not in DDSS’ case.  The stock lost 40% of its value in just a few days.   Read full release here

You can see from the chart here just what I am talking about:

Stocks dropping on news of approvals is not uncommon ( see BDSI, NRIFF, PK and others), but it is still unexpected.   DDSS, the company, actually has a lot going for it.  It has income (no profits), cash in the bank, good ratios, manageable debt….and a big payday coming some time this year.  I have read where DDSS is in talks with several larger pharmaceutical firms regarding the commercialization of their newest drug, Oleptro.  I can only imagine the frenzy at DDSS offices as they take this surprise announcement and try and turn it into revenues.

I am not terribly surprised at the drop given the rise in the share price in anticipation of approval.  And, I am betting that DDSS will come back and come back strong.  Since I am a technical analyst, I will share one last chart with readers that backs up my contention.

This chart shows how volatile the stock has been and I think it is illustrative of the recuperative powers of DDSS.  You can see that the stock is trading within normal ranges and has shown great historical elasticity.  I would not be too worried about this dip and, in fact, would see this as a buying opportunity.  Having said that, there is support at $1.75 and $1.40.  I don’t think it will drop to those levels, but…you never know.

DDSS is both a short-term and a long-term hold.  In the short-term, I could see the stock regaining much of its recent losses.  It certainly seems like the sellers are out.  In the long-term, DDSS could be a “gold mine”.  I will watch with great interest for news on how they will commercialize this and what the financial ramifications are for the company.

I didn’t spend any time in this blog on drug pipelines and other pharma standards.  I expect that my readers will do their own DD.  Here is DDSS’s website link for your own research.

Trade like you mean it!

Jeffrey Dean

Editor-in-Chief

Note on 2/12/10:  DDSS is getting hammered.  The market did not like the news of their $20MM  offering.   DDSS blew through the $1.75 support and is headed down to the $1.40 level.  MIght be best to take an EVEN more cautious approach to this one.